Chemoinformaics analysis of Calconcarboxylic acid
| Molecular Weight | 438.417 | nRot | 4 |
| Heavy Atom Molecular Weight | 424.305 | nRig | 26 |
| Exact Molecular Weight | 438.052 | nRing | 4 |
| Solubility: LogS | -0.521 | nHRing | 0 |
| Solubility: LogP | 4.515 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 4 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 20 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 22 |
| nHA | 7 | APOL | 55.1191 |
| nHD | 4 | BPOL | 22.7089 |
| QED | 0.264 |
| Synth | 2.767 |
| Natural Product Likeliness | -0.017 |
| NR-PPAR-gamma | 0.052 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.59 |
| CACO-2 | -5.682 |
| MDCK | 0.0000111 |
| BBB | 0.002 |
| PPB | 0.992066 |
| VDSS | 0.249 |
| FU | 0.00885967 |
| CYP1A2-inh | 0.372 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.531 |
| CYP2c9-sub | 0.324 |
| CYP2d6-inh | 0.088 |
| CYP2d6-sub | 0.114 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.007 |
| CL | 0.711 |
| T12 | 0.638 |
| hERG | 0.027 |
| Ames | 0.093 |
| ROA | 0.028 |
| SkinSen | 0.445 |
| Carcinogencity | 0.373 |
| EI | 0.308 |
| Respiratory | 0.938 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.673929 |